Our story so far has been a successful one, one of growth and hope. The credit for this success is shared all across Sudarshan Biotech, but the farsightedness of course belongs to our core team. After all, not only did they dream of Sudarshan’s place under the greenfield skies of cutting-edge Biotech research, but also put in honest toil to see that it did happen. Today, Sudarshan Biotech is uniquely placed because it is one of those rare companies that have struck it right with a product range that extends across diverse fields. But then, when a company is helmed just right, success is a normal phenomenon.
Current Openings
We are glad that you have chosen to explore the opportunity to work in our organisation. We are on a continuous look-out for talented professionals. Please submit your CV to us at careers@sudarshanbio.com and we shall get back to you as soon as we have a requirement matching your profile.
Dr. Ramareddy V. Guntaka
Designation: Chairman & Chief Scientist
Brief profile: Dr. Ramareddy V. Guntaka has three decades of hands-on experience in virology and molecular biology and has published extensively in many high impact journals. He was a member of the team that discovered the proto-oncogenes for which the 1989 Nobel Prize was awarded to Drs. H.E.Varmus and J.M.Bishop. Dr. Ramareddy V. Guntaka was also the key person for cloning and commercialization of Hepatitis B vaccine (Shanvac-BTM) and Interferon Alpha 2b (ShanferonTM) by Shantha Biotechnics Ltd, Hyderabad. He is also credited with cloning and sequencing, for the first time, the entire genome of Indian isolates of Hepatitis C Virus. Recently he received the Genome Valley Excellence Award at the Bio Asia 2006, held in February 2006.
Worldwide Patent No. 5,780,611 is an asset to Dr. Ramareddy V. Guntaka for Oligomers, which inhibit expression of Collagen Genes. This nucleic acid-based drug is to control organ fibrosis (liver, kidney, lungs, heart, restenosis, etc.).
Dr. K. Narayana Reddy
Designation: Managing Director
Brief profile: Dr. Narayana Reddy has a vast Research experience in Biomedical sciences at molecular level over 35 years and valuable executive experience of over 20 years in Pharma and Biotech industries. He holds a Ph.D and worked in reputed research institutions in India and abroad like National Institute of Nutrition, Hyderabad and Institute for Physical Biochemistry, Munich, Germany and has guided many doctoral students. He has several research publications of international repute and a commendable US Patent to his credit. He is instrumental in designing and establishing Biochemistry and Drug Screening laboratories at Dr. reddy’s Research Foundation (DRF) of Dr. Reddy’s Labs. He had a versatile experience as Chief of Biochemistry and Scientific Affairs at DRF. He has built motivated drug discovery teams at DRF, where two antidiabetic insulin sensitizer drugs were discovered and subsequently licenced to Novo Nordisk, Denmark for clinical development. As Chief Operating Officer of the emerging Biotech company, DS Genomic Solutions, Hyderabad, he has designed and set up an advanced technical facility for providing genomic services as a CRO.
